Presentation is loading. Please wait.

Presentation is loading. Please wait.

1 TEPRSSC Meeting Presentation October 1, 2003 D. L. Smith UVIR Research Institute [Ultraviolet, Visible and Infrared Radiation] Tucson, AZ.

Similar presentations


Presentation on theme: "1 TEPRSSC Meeting Presentation October 1, 2003 D. L. Smith UVIR Research Institute [Ultraviolet, Visible and Infrared Radiation] Tucson, AZ."— Presentation transcript:

1 1 TEPRSSC Meeting Presentation October 1, 2003 D. L. Smith UVIR Research Institute [Ultraviolet, Visible and Infrared Radiation] Tucson, AZ

2 2 The Indoor Tanning Industry…. Has An Enviable FDA Complaint History My Freedom Of Information Act request showed: 1.84 valid complaints over a 15 year (1985-2000) period. 2.Which means approximately 1 complaint to FDA for every 100 million tanning sessions during this period. An enviable FDA complaint history by any standard! Much of the credit for this enviable complaint history must be given FDA’s Dr. David Lytle and his colleagues for having the courage and the foresight to develop a more protective erythemal action spectrum, the FDA EAS, rather than adopt the less protective CIE EAS in 1985.

3 3 A Paradoxical Role Reversal Situation FDA recommended adopting the same less protective CIE Erythemal Action Spectrum that was rejected by Dr. Lytle and his associates in 1985, a recommendation that will increase the erythemal risk of the American public who, of their own free will, choose to tan. I recommend staying with the more protective FDA Erythemal Action Spectrum developed by Dr. Lytle and his associates that has served us so well since 1985 because doing so decreases the erythemal risk of the American public who choose to tan.

4 4 A Paradoxical Role Reversal Situation In addition, FDA wants to adopt the totally unproven and VERY difficult (if not impossible!) to understand “X/Y Ratio” system for labeling sunlamps. I recommend improving the most protective system in the world – the FDA EAS system - by adding the easy to understand “Bin” system for labeling sunlamps.

5 5 A Paradoxical Role Reversal Situation Paradoxically and counter intuitively, FDA has recommended changing to the less protective CIE erythemal action spectrum while I am recommending staying with the most protective erythemal action spectrum in the world – FDA’s own! Paradoxically and counter intuitively, FDA has recommended the adoption of an unproven and difficult to understand X/Y Ratio sunlamp labeling scheme while I recommend that we adopt the intuitive and easy to understand and implement “Bin” system. At stake in this dispute between politics and science is the safety of the American public who choose, of their own free will, to tan at a professional indoor tanning salon.

6 6 What’s Sauce For The Goose Is Sauce For The Gander Companies under the jurisdiction of FDA must provide proof of efficacy before they are allowed to proceed. Therefore, FDA must be held to the same, or higher, standards of proof before being allowed to make changes to the standards governing the indoor tanning industry. TEPRSSC has the responsibility of making sure that FDA provides adequate proof to support proposed changes that may adversely affect the health and well-being of the American public much like the NASA Safety Committee has the responsibility of making sure that NASA protects the safety of our Astronauts.

7 7 What’s Sauce For The Goose Is Sauce For The Gander FDA provided inadequate proof to support changing from the more protective FDA EAS to the less protective CIE EAS. FDA has not conducted adequate studies to support adopting the Non-Melanoma Skin Cancer Action Spectrum. FDA has not considered the needless confusion that adopting the X/Y coding scheme for labeling sunlamps will cause. FDA ignored the negative response that the X/Y system received when it was discussed in February, 2001. Instead, FDA requests that these draconian changes be adopted in order to achieve the political goal of Global Harmonization.

8 8 Why Is The FDA EAS More Protective Than The CIE EAS? Broader 1.0 Weighting Factor Used By FDA EAS -280 – 298 nm (CIE) vs 280 – 302 nm (FDA) -CIE EAS is 28% less protective than FDA EAS

9 9 Why Is The FDA EAS More Protective Than The CIE EAS? FDA EAS is weighted more stongly than the CIE EAS

10 10 Why Is The FDA EAS More Protective Than The CIE EAS? FDA EAS is weighted more stongly than the CIE EAS

11 11 Why Is The FDA EAS More Protective Than The CIE EAS? More Conservative J/m^2 Threshold Per MED -200 J/m^2/MED (CIE) vs 156 J/m^2/MED (FDA) -CIE EAS is 22% less protective than FDA EAS

12 12 Why The FDA EAS Is More Protective Than The CIE EAS Thus, the theoretical difference between the FDA EAS and the CIE EAS with regards to the T e (time to 4.0 MED) time when you consider the difference in the 1.0 weighting factor range and the different J/m^2 threshold levels is: -1.0 (FDA EAS) to 1.5 (CIE EAS)

13 13 Why The FDA EAS Is More Protective Than The CIE EAS We found that the ratio between them changes as the UVB/UVA2 percentage increases

14 14 Why The FDA EAS Is More Protective Than The CIE EAS And changing the MAD from 800 to 600 J/m^2 doesn’t solve the problem

15 15 Why The FDA EAS Is More Protective Than The CIE EAS Adopting CIE AS Increases The Risk To American Public Who Choose To Tan

16 16 Why FDA’s Proposed X/Y Labeling System Is A Step Backward X Axis Label = Weighted total irradiance value using CIE EAS - In mW/cm^2 ???? = 100.0 mW/cm^2 ???? Y Axis Label = Ratio of 250-320 nm to 320-400 nm using the Non- Melanoma Skin Cancer Action Spectrum -0.3 W/m^2 : 0.3 W/m^2 = 1.0 Ratio ???? X/Y Ratio = 100.0 mW/cm^2 : 1.0 Ratio = 1% Skin Cancer Power ???? XY Values derived from testing a single lamp in a test stand -No provision for measuring an array of sunlamps.

17 17 Why FDA’s Proposed X/Y Labeling System Is A Step Backward Weighted total irradiance value (X axis) is not as useful as the current T e (time to 4.0 MED) time calculation because relying on total irradiance “masks” the differences caused by the UVB/UVA2 lack of linearity problem. Using the weighted NMSC AS ratio (Y axis) is totally unproven! Values obtained by testing a single lamp in a test stand, under controlled conditions, are useful for determining sunlamp compatibility but they are not adequate for calculating exposure schedules. For that, the complete array of sunlamps, i.e., the sunbed must be tested under standard conditions. Thus, the proposed FDA X/Y sunlamp labeling system only addresses the easy half of the problem. FDA’s labeling scheme will result in a massive amount of confusion which will adversely affect the indoor tanning industry, the regulatory community and the American public who chooses to tan.

18 18 The Ideal Sunlamp Labeling System Must Be Easy To Understand By All Segments Of Industry. -Tanning salon owners - Vendors -Regulators -Clients Must Be Logical And Intuitive. Must Be Easy And Inexpensive To Implement. Must Be Able To Resolve Two “Festering” Problems. -Determining sunlamp compatibility -Determining exposure schedules

19 19 Easy To Understand and Logical And Intuitive The indoor tanning industry classifies, and talks about, their sunbeds according to their MTI (Maximum Timer Interval). Thus, we have: -30 minute (MTI) sunbeds -20 minute (MTI) sunbeds -15 minute (MTI) sunbeds -12 minute (MTI) sunbeds -10 minute (MTI) sunbeds - 8 minute (MTI) sunbeds - 6 minute (MTI) sunbeds The “ideal system for labeling sunlamps” must, therefore, recognize and accept this important “real world” fact of life!

20 20 Only The Bin System Meets ALL OF The “Ideal Sunlamp Labeling System” Requirements

21 21 Only The Bin System Meets ALL OF The “Ideal Sunlamp Labeling System” Requirements

22 22 Compare The Simplicity Of The Bin System To The Complexity of X/Y System Proposed X/Y Ratio System: X = 100.0 mW/cm^2 of absolute erythemal weighted irradiance to: Y = 1.0 ratio (250-320 vs 320-400) of skin cancer power ????? X/Y Ratio = 100.0:1.0 ratio = 1% skin cancer power ????? Proposed Bin System: 20 minute T e (time to 4.0 MED) time (17 – 30 minute T e time range) absolute erythemal weighted irradiance.

23 23 The Y Axis Recommendation Is A Political Recommendation Non-Melanoma Skin Cancer Action Spectrum Is An Action Spectrum For: 1. Squamous Cell Carcinoma. 2. In albino mice. 3. That were irradiated with sunlamps containing UVC and abnormally high levels of UVB.

24 24 The Y Axis Recommendation Is A Political Recommendation Non-Melanoma Skin Cancer Action Spectrum Is Not An Action Spectrum For: 1. Evaluating the spectral characteristics of the sunlamps used by the USA indoor tanning industry. 2. Estimating the “dose response” human risk of developing squamous cell carcinoma. 3. Labeling sunlamps for commercial purposes.

25 25 The Y Axis Recommendation Is A Political Recommendation

26 26 The Y Axis Recommendation Is A Political Recommendation

27 27 The Y Axis Recommendation Is A Political Recommendation

28 28 The Y Axis Recommendation Is A Political Recommendation

29 29 The Y Axis Recommendation Is A Political Recommendation

30 30 The Y Axis Recommendation Is A Political Recommendation

31 31 The Y Axis Recommendation Is A Political Recommendation What respected photobiologists say about the FS 40 sunlamp: 1.“Fluorescent sunlamps are commonly employed as convenient sources in photobiology experiments. The ability of Kodacel to filter photobiologically irrelevant UVC wavelengths has been described. Yet there still remains a major unaddressed issue—the over representation of UVB in the output. The shortest terrestrial solar wavelengths the surface are >295 nm with the 295-320 nm range comprising 4% of the solar UV irradiance. In Kodacel-filtered sunlamps, 47% of the UV output falls in this range. Consequently, in studies designed to understand skin photobiology after solar exposure, the use of these sunlamps may result in misleading, or even incorrect, conclusions.” Brown, et al, Photochemistry and Photobiology, 2000, 72(3): 340-344 “Common Fluorescent Sunlamps are an Inappropriate Substitute for Sunlight.”

32 32 The Y Axis Recommendation Is A Political Recommendation Summary – Non-Melanoma Skin Cancer Action Spectrum NMSC-AS is an inappropriate action spectrum - It “devalues” the wavelengths associated with causing NMSC. -Mouse to human skin conversion factor not scientifically valid. - Irradiance source used does not “mimic” sunlight or sunlamps. NMSC-AS is a political proposal, not a scientific proposal - To get the word “cancer” incorporated into Sunlamp Standards! - To ultimately adopt unrealistic annual UVR dose limits. NMSC-AS will financially damage the indoor tanning industry. NMSC-AS will make it difficult for vendors and salon owners to find liability insurance coverage at a price they can afford. NMSC-AS will encourage the American public to avoid needed sensible, moderate and responsible UVR exposure. NMSC-AS adoption will inevitably cause unintended consequences.

33 33 Warning Label Comments – FDA Version WARNING - Ultraviolet radiation may cause: - injury to the eyes and skin -skin aging -skin cancer Read instructions carefully. Wear protective eyewear provided. Certain medicines and cosmetics may increase sensitivity to ultraviolet radiation.

34 34 Warning Label Comments – DLS Version WARNING - Overexposure to ultraviolet radiation may cause: - injury to the eyes and skin -skin aging -skin cancer Read instructions carefully. Wear protective eyewear provided. Individuals taking a medication or using a cosmetic product that may increase their sensitivity to ultraviolet radiation should check with their physician or pharmacist before tanning. Individuals with systemic lupus erythematosus, rosacea or who have received medical treatment for a diagnosis of skin cancer should check with their physician before tanning.

35 35 Definition of a Manufacturer – DLS Response My response is exactly the same as it was last year. - If you do not have a “standard protocol” for measuring performance, you can’t have a fair and equitable regulation that depends upon the measurement of performance. Thus, we need a standard protocol for testing an array of sunlamps, i.e., a sunbed, before adopting the “Definition of a Manufacturer” Amendment.

36 36 Eyewear Tests – 10 Leading Products 10,000 LUX Lamp = 0.150 MED/hour = 400 minutes to 1.0 MED Weakest Eyewear = 0.013 MED/hour = 4500 minutes to 1.0 MED All eyewear tested meet or exceeded UVR requirements. - 0.001% - 200 nm – 320 nm -0.01% - 320 nm – 400 nm The problem is in the 400 nm – 550 nm range (5 nm increments). -436 – 440 = 26.1% -541 – 545 = 7.4% -546 – 550 = 15.7% -All other 5 nm ranges are below 0.8% -Average = 2.27% Thus, the “mercury peaks” found at 436-440 nm and 540-550 nm in the lamps are the cause of the problem.

37 37 Eyewear Tests – 10 Leading Products

38 38 Eyewear Tests – 10 Leading Products

39 39 Closing Request Of TEPRSSC Approve FDA’s Request To: - Adopt the “revised” warning label language. -Include revised warning label language on sunbeds, sunlamps and in catalogs, brochures, etc. Instruct FDA to: -Do more testing of available eyewear products before finalizing protective eyewear requirements. -Instruct FDA to develop standard protocols for testing sunlamps and sunbeds before moving forward with Definition of a Manufacturer Amendment because if you can’t measure performance, it can’t be enforced.

40 40 Closing Request Of TEPRSSC Reject FDA’s Request To: - Change from more protective FDA EAS to the less protective CIE EAS. - Adopt the totally unproven and politically motivated X/Y Ratio system. Instruct FDA To: -Work with industry to improve the more protective FDA EAS. -M ake protecting the American public, not global harmonization, their first priority!

41 41 AMERICA FIRST!AMERICA FIRST!

42 42 TEPRSSC Presentation Irradiance Caps IEC APPLIANCE TYPES TypeEffective IrradianceEffective IrradianceTotal Irradiance 250 nm – 320 nm 320 nm – 400 nm 250 nm – 400 nm (W/m^2) (W/m^2) (W/m^2) 1 0.15 < 0.1505 2 0.0005 to 0.15 > 0.15 < 0.1505 – 0.3 3 0.15 < 0.3 4 > 0.15 > 0.15 > 0.3

43 43 TEPRSSC Presentation Irradiance Caps Type 3 Appliance Effective Irradiance Effective Irradiance Total Irradiance Te Time Te Time 250 nm – 320 nm 320 nm – 400 nm 250 nm – 400 nm FDA CIE (W/m^2) (W/m^2) (W/m^2) (Minutes) (Minutes) < 0.15 < 0.15 < 0.3 34 44 < 0.3 < 0.3 < 0.6 17 22 < 0.6 < 0.6 < 1.2 9 11 < 0.75 < 0.75 < 1.5 7 9 < 0.9 < 0.9 < 1.8 6 7

44 44 The Y Axis Recommendation Is A Political Recommendation Non-Melanoma Skin Cancer Action Spectrum Is An Attempt To: 1. Make a political statement that ignores the scientific facts. 2. Adopt unwarranted and unnecessary annual UVR dose limits. 3. Damage the USA indoor tanning industry financially. 4. Enact a “de facto” ban of the indoor tanning industry. That will: 5. Unintentionally damage the American public. 6. Put other “sunshine dependant” industries in jeopardy.

45 45 Calculation Denominator Analysis - MED A B C D WMO FORMULA FDA – EXISTING CIE & FDA – PROPOSED UViR-RI PROPOSAL 1. 1 MED =210 J/m^2 156 J/m^2 200 J/m^2 180 J/m^2 2. And 1 MED = 21 mJ/cm^2 15.6 mJ/cm^2 20 mJ/cm^2 18 mJ/cm^2 3. And 1 MED = (1 Joule = 1 watt/second) 210,000 mJ/m^2 156,000 mJ/m^2 200,000 mJ/m^2 180,000 mJ/m^2 4. Thus, 1 MED = 210,000 mW/sec/m^2 156,000 mW/sec/m^2 200,000 mW/sec/m^2 180,000 mW/sec/m^2 5. Therefore, 1 MED = (3600 seconds/hour)58.33 mW/hour 43.33 mW/hour 55.56 mW/hour 50.00 mW/hour 6. And 1 MED/hour =58.33 mW/m^2 43.33 mW/m^2 55.56 mW/m^2 50.00 mW/m^2

46 46 Conversion Factors Action SpectraEPA/NWSFDACIEUVIR-RI Reference Value1 MED1 MED1 MED1 MED J/m^2210156200180 mJ/cm^221.015.620.018.0 J/cm^20.0210.01560.020.018 microwatts/m^258,30043,30055,60050,000 mW/m^258.343.355.650.0 microwatts/cm^25.834.335.565.00 W/m^20.05830.04330.05560.05 mW/cm^20.005830.00430.005560.005 W/cm^20.000005830.000004330.000005560.000005


Download ppt "1 TEPRSSC Meeting Presentation October 1, 2003 D. L. Smith UVIR Research Institute [Ultraviolet, Visible and Infrared Radiation] Tucson, AZ."

Similar presentations


Ads by Google